COMPOUNDS AND METHODS FOR TREATING CANCER
Patent number:
EP4019634
No items found.
-
Countries:
Spain
Regions:
Galicia
Centers:
UNIVERSIDAD DE SANTIAGO DE COMPOSTELA, SERGAS
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
Applications
The present invention is based on the finding that inhibition of the expression of the PIAS2β protein results in specific inhibition of the proliferation of and the induction of death of cells of undifferentiated or poorly differentiated carcinoma of the thyroid gland. Therefore, inhibition of PIAS2β gives rise to a reduction in growth of carcinomas of this type. Furthermore, the inventors have surprisingly observed that the PIAS2β protein is less expressed in cells of undifferentiated or poorly differentiated carcinoma of the thyroid gland than in the cells of normal tissue or in the cells of differentiated papillary carcinoma of the thyroid.
Comments
Other related patents
Health
LABORATORY ANIMAL HOUSING SYSTEM FOR THE STUDY OF THE TRANSMISSION OF INFECTIOUS AGENTS THROUGH DIRECT CONTACT (MACHINE-TRANSLATION BY GOOGLE TRANSLATE, NOT LEGALLY BINDING)
Health
Divisional Patent Application No. 202531012, relating to “METHODS FOR PREDICTING THE RISK OF KIDNEY DAMAGE BY DETECTING BINUCLEATED PODOCYTES IN URINE.”
Health

32.jpg)


56.jpg)